Nabi Biopharmaceuticals
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Nabi Biopharmaceuticals - overview
Established
1967
Location
Rockville, MD, US
Primary Industry
Biotechnology
About
Based in Maryland, US, and founded by Raafat Fahim in 1967, Nabi Biopharmaceuticals operates as a biopharmaceutical company specializing in the creation of vaccination medicines for the treatment of nicotine addiction and prevention of smoking relapse. In November 2012, the firm was acquired by Aviragen Therapeutics.
Primary Industry
Biotechnology
Sub Industries
Biopharmaceuticals
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.